Ownership history in Qube Research & Technologies Ltd · 17 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in CLOVER HEALTH INVESTMENTS CO (CLOV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 368,065 | -1,746,937 | -82.6% | 0.00% | $1.1M | $3.06 |
| 2025 Q2 | REDUCED | 2,115,002 | -2,210,707 | -51.1% | 0.01% | $5.9M | $2.79 |
| 2025 Q1 | REDUCED | 4,325,709 | -382,053 | -8.1% | 0.02% | $15.5M | $3.59 |
| 2024 Q4 | ADDED | 4,707,762 | +1,949,126 | +70.7% | 0.02% | $14.8M | $3.15 |
| 2024 Q3 | ADDED | 2,758,636 | +737,827 | +36.5% | 0.01% | $7.8M | $2.82 |
| 2024 Q2 | REDUCED | 2,020,809 | -406,687 | -16.8% | 0.00% | $2.5M | $1.23 |
| 2024 Q1 | REDUCED | 2,427,496 | -326,618 | -11.9% | 0.00% | $1.9M | $0.79 |
| 2023 Q4 | ADDED | 2,754,114 | +1,399,773 | +103.4% | 0.01% | $2.6M | $0.95 |
| 2023 Q3 | ADDED | 1,354,341 | +131,242 | +10.7% | 0.00% | $1.5M | $1.08 |
| 2023 Q2 | REDUCED | 1,223,099 | -166,817 | -12.0% | 0.00% | $1.1M | $0.90 |
As of 2025 Q4 — sorted by position size